Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program

Non-vitamin K antagonist oral anticoagulants such as edoxaban are the standard of care for stroke prevention in patients with atrial fibrillation (AF). The Global Edoxaban Treatment in routiNe clinical prActice (ETNA)-AF program integrates prospective, observational, noninterventional regional studi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Caterina, Raffaele, Kim, Young-Hoon, Koretsune, Yukihiro, Wang, Chun-Chieh, Yamashita, Takeshi, Chen, Cathy, Reimitz, Paul-Egbert, Unverdorben, Martin, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913627/
https://www.ncbi.nlm.nih.gov/pubmed/33546442
http://dx.doi.org/10.3390/jcm10040573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913627/
https://www.ncbi.nlm.nih.gov/pubmed/33546442
http://dx.doi.org/10.3390/jcm10040573

Ejemplares similares